We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$6.03B
AUM Growth
+$40.9M
Cap. Flow
-$218M
Cap. Flow %
-3.61%
Top 10 Hldgs %
43.48%
Holding
189
New
53
Increased
23
Reduced
34
Closed
73

Top Buys

Rank Stock Value
1
DHI icon
D.R. Horton
DHI
+$153M
2
APTV icon
Aptiv
APTV
+$74.7M
3
S icon
SentinelOne
S
+$72.6M
4
BKNG icon
Booking.com
BKNG
+$72.6M
5
CRM icon
Salesforce
CRM
+$61.7M

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Consumer Discretionary 12.61%
3 Communication Services 6.3%
4 Healthcare 3.85%
5 Industrials 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CF icon
101
CF Industries
CF
$19.6B
$3.5M 0.06%
+49,495
New +$3.1M
HZNP
102
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.69M 0.04%
25,000
-20,000
-44% -$2.18M
CANO
103
DELISTED
Cano Health, Inc.
CANO
$2.58M 0.04%
2,901
-4,461
-61% -$4.69M
OSH
104
DELISTED
Oak Street Health, Inc.
OSH
$2.49M 0.04%
+75,000
New +$2.84M
AMED
105
DELISTED
Amedisys
AMED
$2.43M 0.04%
+15,000
New +$2.41M
PRVA icon
106
Privia Health
PRVA
$3.07B
$2.3M 0.04%
+89,000
New +$2.22M
ONEM
107
DELISTED
1Life Healthcare
ONEM
$2.09M 0.03%
+119,000
New +$2.31M
RDNT icon
108
RadNet
RDNT
$4.97B
$1.66M 0.03%
55,000
-25,000
-31% -$736K
CTLT
109
DELISTED
CATALENT, INC.
CTLT
$1.6M 0.03%
+12,500
New +$1.61M
ALT icon
110
Altimmune
ALT
$583M
$1.24M 0.02%
135,000
+75,000
+125% +$797K
MRNA icon
111
Moderna
MRNA
$22B
$1.01M 0.02%
3,990
+690
+21% +$202K
ENTA icon
112
Enanta Pharmaceuticals
ENTA
$369M
$1.01M 0.02%
+13,500
New +$1.06M
BNTX icon
113
BioNTech
BNTX
$23.8B
$1.01M 0.02%
3,908
+408
+12% +$112K
ABUS icon
114
Arbutus Biopharma
ABUS
$857M
$778K 0.01%
+200,000
New +$777K
NEE icon
115
NextEra Energy
NEE
$185B
$633K 0.01%
+6,778
New +$586K
OTLKW
116
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$10K ﹤0.01%
100,000
ABBV icon
117
AbbVie
ABBV
$471B
-230,267
Closed -$27.2M
ABT icon
118
Abbott
ABT
$189B
-85,000
Closed -$10M
AGL icon
119
Agilon Health
AGL
$1.59B
-1,400
Closed -$917K
ALL icon
120
CALL
Allstate
ALL
$70.4B
-500,000
Closed -$63.7M
ALL icon
121
Allstate
ALL
$70.4B
-1,728,565
Closed -$220M
AVTR icon
122
CALL
Avantor
AVTR
$9.68B
-100,000
Closed -$4.09M
AZN icon
123
AstraZeneca
AZN
$270B
-410,950
Closed -$48.4M
BAX icon
124
Baxter International
BAX
$12.8B
-90,000
Closed -$7.24M
BIIB icon
125
CALL
Biogen
BIIB
$30.6B
-40,000
Closed -$11.3M

Similar funds

PointState Capital's Q4 2021 Portfolio in Review

As of Q4 2021, PointState Capital held 189 positions worth $6.03B, up 0.68% from $5.99B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

PointState Capital withdrew a net $218M in Q4 2021, closing 73 positions and reducing 34 holdings. Its most notable exit was Allstate, an estimated $220M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, PointState Capital opened a new position in D.R. Horton worth $173M.

  • PointState Capital's largest Q4 2021 buy was D.R. Horton: 1,593,008 shares worth $173M.
  • PointState Capital added most to Aptiv in Q4 2021, an estimated $74.7M increase.
  • PointState Capital's biggest Q4 2021 reduction was Palo Alto Networks, cutting an estimated $168M.
  • PointState Capital fully exited Allstate in Q4 2021, selling an estimated $220M.
  • PointState Capital's ten largest holdings make up 43% of its $6.03B portfolio in Q4 2021.
  • PointState Capital opened 53 new positions and closed 73 in Q4 2021.
  • PointState Capital's portfolio value rose 0.68% quarter-over-quarter to $6.03B.

Based on PointState Capital's 13F filing for Q4 2021, filed 11 Feb 2022.